Anti-HER2 Drug Fails to Win FDA Fast Track

posted on Aug 27 by MedPage Today OB/Gyn in the Uncategorized category WASHINGTON (MedPage Today) -- The Food and Drug Administration turned down a request for accelerated approval of Roche-Genentech's trastuzumab-DM1 for treatment of HER2-positive breast cancer.